or
forgot password
  • cancer clinical trials in hutchinson, KS

  • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Trial of Myocet in Metastatic Breast Cancer
    Hutchinson Clinic P.A.
    Hutchinson, Kansas 67502
    Breast Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Prostate Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Bladder Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Colorectal Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer
    Hutchinson Clinic, PA
    Hutchinson, Kansas 67502
    Non Small Cell Lung Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Hutchinson Clinic, PA
    Hutchinson, Kansas 67502
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Dinaciclib in Treating Patients With Stage IV Melanoma
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Mucosal Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Hutchinson Clinic, PA
    Hutchinson, Kansas 67502
    Prostate Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Prostate Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Hutchinson Clinic
    Hutchinson, Kansas 67502
    Chronic Myeloid Leukemia
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Prostate Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Colorectal Neoplasms
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Hutchinson Clinic
    Hutchinson, Kansas 67502
    Multiple Myeloma
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Hutchinson Hospital Corporation
    Hutchinson, Kansas 67502
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Hutchinson Clinic, PA
    Hutchinson, Kansas 67502
    Multiple Myeloma
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Promise Regional Medical Center-Hutchinson
    Hutchinson, Kansas 65702
    Recurrent Melanoma, Stage IV Melanoma
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Hutchinson Clinic
    Hutchinson, Kansas 67502
    Relapsed Follicular Lymphoma